CSIMarket Company Name, Ticker, Competitors, else..


Bluebird Bio Inc   (NASDAQ: BLUE)
Other Ticker:  
 

Bluebird Bio Inc

BLUE's Fundamental analysis



Bluebird Bio Inc 's sales fell by -14.36 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 71

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Bluebird Bio Inc realized net income compared to net loss a year ago in III. Quarter 2024

• More on BLUE's Growth


Bluebird Bio Inc
realized a net loss in trailing twelve months.

Bluebird Bio Inc realized cash reduction of $ -10.29 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.52.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.6.


• More on BLUE's Valuation
 
 Total Debt (Millions $) 71
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 169,712
 Net Income/Employee (TTM) $ -51,265
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -2.19

Bluebird Bio Inc
realized net loss in trailing twelve months.

Bluebird Bio Inc realized cash outflow of $ -10.29per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.52.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.6.


• More on BLUE's Valuation

•  Market Capitalization (Millions $) 81
•  Shares Outstanding (Millions) 10
•  Employees 313
•  Revenues (TTM) (Millions $) 53
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) -100
•  Capital Exp. (TTM) (Millions $) -7
•  Total Debt (Millions $) 71
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 169,712
•  Net Income/Employee(TTM) $ -51,265
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -2.19

•  Market Capitalization (Millions $) 81
•  Shares Outstanding (Millions) 10
•  Employees 313
•  Revenues (TTM) (Millions $) 53
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) -100
•  Capital Exp. (TTM) (Millions $) -7





  Ratio
•   Capital Ratio (MRQ) 0.51
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.14
•  Inventory Turnover Ratio (TTM) 2.17





Bluebird Bio Inc net profit margin of 0.55 % is currently ranking no. 18 in Biotechnology & Pharmaceuticals industry, ranking no. 193 in Healthcare sector and number 2244 in S&P 500.

• More on BLUE's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com